124 related articles for article (PubMed ID: 36370483)
1. Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin.
Vazirabad AF; Noorolyai S; Baghbani E; Mahboob S; Zargari F; Rahmani S; Sorkhabi A; Montazami N; Sameti P; Baradaran B
Pathol Res Pract; 2022 Dec; 240():154194. PubMed ID: 36370483
[TBL] [Abstract][Full Text] [Related]
2. Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells.
Mohammadpour ZJ; Mohammadzadeh R; Javadrashid D; Baghbanzadeh A; Doustvandi MA; Barpour N; Baradaran B
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2741-2751. PubMed ID: 37093251
[TBL] [Abstract][Full Text] [Related]
3. B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
Mohammadi A; Najafi S; Amini M; Baradaran B; Firouzamandi M
Melanoma Res; 2023 Jun; 33(3):173-183. PubMed ID: 37053079
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction.
Heiat M; Rezaei E; Gharechahi J; Abbasi M; Behroozi J; Abyazi MA; Baradaran B
Med Oncol; 2023 Sep; 40(10):287. PubMed ID: 37656231
[TBL] [Abstract][Full Text] [Related]
5. Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.
Baghbani E; Noorolyai S; Rahmani S; Shanehbandi D; Shadbad MA; Aghebati-Maleki L; Mokhtarzadeh A; Brunetti O; Fasano R; Silvestris N; Baradaran B
Biomed Pharmacother; 2022 Jan; 145():112370. PubMed ID: 34862113
[TBL] [Abstract][Full Text] [Related]
6. Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells.
Vasefifar P; Najafi S; Motafakkerazad R; Amini M; Safaei S; Najafzadeh B; Alemohammad H; Jafarlou M; Baradaran B
Exp Cell Res; 2023 Aug; 429(2):113681. PubMed ID: 37315760
[TBL] [Abstract][Full Text] [Related]
7. Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration.
Najafzadeh B; Motafakkerazad R; Najafi S; Amini M; Alemohammad H; Vasefifar P; Baradaran B
Pathol Res Pract; 2022 May; 233():153869. PubMed ID: 35398618
[TBL] [Abstract][Full Text] [Related]
8. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer.
Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701
[TBL] [Abstract][Full Text] [Related]
10. Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?
Bolandi N; Khadem Ansari MH; Rasmi Y; Baradaran B
Adv Pharm Bull; 2023 Jul; 13(3):573-582. PubMed ID: 37646055
[TBL] [Abstract][Full Text] [Related]
11. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
Gene; 2022 May; 821():146333. PubMed ID: 35182674
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
Chang F; Li J; Sun Q; Wei S; Song Y
Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
[TBL] [Abstract][Full Text] [Related]
13. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
14. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
Han J; Hu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
[TBL] [Abstract][Full Text] [Related]
15. Slc12a2 is a direct target of two closely related homeobox proteins, Six1 and Six4.
Ando Z; Sato S; Ikeda K; Kawakami K
FEBS J; 2005 Jun; 272(12):3026-41. PubMed ID: 15955062
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis.
Liu P; Cai S; Li N
Exp Cell Res; 2020 Sep; 394(2):112141. PubMed ID: 32535033
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma.
Li Y; Jiang X; Yan X; Wang Y
Thorac Cancer; 2021 Mar; 12(6):752-759. PubMed ID: 33481352
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.
Esfandyari YB; Doustvandi MA; Amini M; Baradaran B; Zaer SJ; Mozammel N; Mohammadzadeh M; Mokhtarzadeh A
Reprod Sci; 2021 Jul; 28(7):2036-2049. PubMed ID: 33569751
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.
Zhang M; Shi H; Zhang C; Zhang SQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4807-4814. PubMed ID: 31210312
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]